Histamine induces NF-κB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1.

[1]  S. Plötz,et al.  Influence of histamine on the expression of CCL20 in human gingival fibroblasts. , 2015, Journal of periodontal research.

[2]  Heung-Man Lee,et al.  Stimulatory effects of histamine on migration of nasal fibroblasts , 2015, International forum of allergy & rhinology.

[3]  S. Moshkelgosha,et al.  Modeling Graves’ Orbitopathy in Experimental Graves’ Disease , 2015, Hormone and Metabolic Research.

[4]  W. Dik,et al.  Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts. , 2015, Investigative ophthalmology & visual science.

[5]  B. Kos-Kudła,et al.  Serum concentrations of HGF and IL-8 in patients with active Graves’ orbitopathy before and after methylprednisolone therapy , 2015, Journal of Endocrinological Investigation.

[6]  W. Dik,et al.  Platelet-Derived Growth Factor: A Key Factor in the Pathogenesis of Graves' Ophthalmopathy and Potential Target for Treatment , 2014, European Thyroid Journal.

[7]  Y. Fukushima,et al.  Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis. , 2014, Clinical science.

[8]  T. Naka,et al.  Histamine contributes to tissue remodeling via periostin expression. , 2014, The Journal of investigative dermatology.

[9]  Seung Hoon Lee,et al.  Histamine Promotes the Release of Interleukin-6 via the H1R/p38 and NF-κB Pathways in Nasal Fibroblasts , 2014, Allergy, asthma & immunology research.

[10]  J. Nakajima,et al.  Histamine induces human lung fibroblast-mediated collagen gel contraction via histamine H1 receptor , 2014, Experimental lung research.

[11]  Terry J. Smith,et al.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. , 2014, Investigative ophthalmology & visual science.

[12]  J. Sévigny,et al.  Histamine Induces ATP Release from Human Subcutaneous Fibroblasts, via Pannexin-1 Hemichannels, Leading to Ca2+ Mobilization and Cell Proliferation* , 2013, The Journal of Biological Chemistry.

[13]  S. Worgall,et al.  Mast cells: a pivotal role in pulmonary fibrosis. , 2013, DNA and cell biology.

[14]  Koichiro Nakamura,et al.  Cetirizine hydrochloride suppresses the CCL17 production of epidermal keratinocytes and dermal fibroblasts , 2012, International journal of dermatology.

[15]  H. Drexhage,et al.  PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients. , 2012, The Journal of clinical endocrinology and metabolism.

[16]  R. Kuijpers,et al.  Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  L. DiPietro,et al.  Mast Cells Contribute to Scar Formation During Fetal Wound Healing , 2011, The Journal of investigative dermatology.

[18]  S. Feldon,et al.  Mast Cell-derived Prostaglandin D2 Controls Hyaluronan Synthesis in Human Orbital Fibroblasts via DP1 Activation , 2010, The Journal of Biological Chemistry.

[19]  R. Kuijpers,et al.  Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy. , 2010, Investigative ophthalmology & visual science.

[20]  C. Akdis,et al.  Histamine, histamine receptors and their role in immune pathology , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  G. Ning,et al.  Association studies of interleukin-8 gene in Graves’ disease and Graves’ ophthalmopathy , 2009, Endocrine.

[22]  M. Ludgate,et al.  Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts , 2009, The Journal of Biological Chemistry.

[23]  H. Drexhage,et al.  Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy. , 2009, Investigative ophthalmology & visual science.

[24]  S. S. Franceschini,et al.  Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  S. Holdsworth,et al.  Role of mast cells in progressive renal diseases. , 2008, Journal of the American Society of Nephrology : JASN.

[26]  L. Chuang,et al.  Role of macrophage infiltration in the orbital fat of patients with Graves’ ophthalmopathy , 2008, Clinical endocrinology.

[27]  S. Mccormick,et al.  Oral Montelukast and Cetirizine for Thyroid Eye Disease , 2008, Ophthalmic plastic and reconstructive surgery.

[28]  H. Shimauchi,et al.  Histamine Amplifies Immune Response of Gingival Fibroblasts , 2007, Journal of dental research.

[29]  Y. Sasaguri,et al.  Histamine Upregulates the Expression of Inducible Nitric Oxide Synthase in Human Intimal Smooth Muscle Cells via Histamine H1 Receptor and NF-&kgr;B Signaling Pathway , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[30]  C. Akdis,et al.  Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. , 2007, The Journal of allergy and clinical immunology.

[31]  P. Conti,et al.  Differential release of mast cell mediators and the pathogenesis of inflammation , 2007, Immunological reviews.

[32]  F. Grizzi,et al.  The Complex Functions of Mast Cells in Chronic Human Liver Diseases , 2006, Digestive Diseases and Sciences.

[33]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[34]  S. S. Franceschini,et al.  Interferon-γ-Inducible α-Chemokine CXCL10 Involvement in Graves’ Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists , 2006 .

[35]  S. Costagliola,et al.  Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy , 2005, British Journal of Ophthalmology.

[36]  K. Steuhl,et al.  Thyroid associated ophthalmopathy: evidence for CD4+ γδ T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of γδ and αβ T cell receptor expression , 2004, British Journal of Ophthalmology.

[37]  M. Kramer,et al.  MAST CELLS INDUCE ACTIVATION OF HUMAN LUNG FIBROBLASTS IN VITRO , 2004, Experimental lung research.

[38]  Seema Kumar,et al.  Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy. , 2003, The Journal of clinical endocrinology and metabolism.

[39]  O. Ishikawa,et al.  Effect of activated human mast cells and mast cell-derived mediators on proliferation, type I collagen production and glycosaminoglycans synthesis by human dermal fibroblasts. , 2002, European journal of dermatology : EJD.

[40]  M. Ludgate,et al.  Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. , 2002, The Journal of clinical endocrinology and metabolism.

[41]  A. Nagler,et al.  Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  M. Ludgate,et al.  Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease , 2002, Clinical and experimental immunology.

[43]  Terry J. Smith,et al.  Igs from Patients with Graves’ Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts1 , 2002, The Journal of Immunology.

[44]  S. Jyonouchi,et al.  Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy. , 2001, Thyroid : official journal of the American Thyroid Association.

[45]  T. Bednarczuk,et al.  Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  Y. Nakamura,et al.  A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.

[47]  T. Smith,et al.  HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. , 1999, Endocrinology.

[48]  Y. Nakamura,et al.  An elevation of stem cell factor in patients with hyperthyroid Graves' disease. , 1998, Thyroid : official journal of the American Thyroid Association.

[49]  C. Balázs,et al.  Detectable serum IgE levels in Graves' ophthalmopathy. , 1996, European Journal of Medical Research.

[50]  S. Holgate,et al.  Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. , 1991, Clinical science.

[51]  W. Hiller,et al.  Immunohistochemical evidence for IgE involvement in Graves' orbitopathy. , 1990, Ophthalmology.

[52]  M. Kaliner,et al.  Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis. , 1987, The Journal of allergy and clinical immunology.

[53]  G. Asboe-hansen,et al.  Retrobulbar connective tissue changes in malignant exophthalmos. , 1957, Acta endocrinologica.

[54]  W. Dik,et al.  Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy. , 2016, Experimental eye research.

[55]  R. Bahn.  Graves' ophthalmopathy. , 2010, The New England journal of medicine.

[56]  D. Shen.  A target role for mast cell in the prevention and therapy of hepatic fibrosis. , 2008, Medical hypotheses.

[57]  Yoshiro Kobayashi.  The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.

[58]  Fu-you Liu,et al.  Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. , 2007, Medical hypotheses.

[59]  S. S. Franceschini,et al.  Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. , 2006, The Journal of clinical endocrinology and metabolism.

[60]  K. Steuhl,et al.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression. , 2004, The British journal of ophthalmology.

[61]  T. Hirano.  Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.